Humira has been the world’s best selling medicine since it arrived on the market in 2002. Now, it is finally getting ...

A technological revolution is helping Scripps Research scientists see the molecules that undermine human health, from ...

AbbVie lifted its full-year adjusted EPS profit forecast to a range of $12.09 to $12.29 from the prior $11.99 to $12.19. The ...

Rova-T was supposed to be the cancer drug that would bolster AbbVie’s revenues as revenues from the $20bn a year Humira (adalimumab ... perhaps with the usual pictures of shrinking tumours ...

Sanofi’s development of an oral spin on Humira’s mechanism has hit a setback. | Sanofi’s development of an oral spin on ...

AbbVie Inc. beat revenue & EPS estimates, raised guidance due to Skyrizi & Rinvoq growth. Immunology shines; future ...

After years of patent protection, biosimilars for Humira are set to enter the US market in 2023. The arrival of these drugs has been widely anticipated throughout the healthcare industry.

AbbVie generated $56 billion in revenue, achieving an operating profit of $12 billion and a net income of $4.3 billion, ...

AbbVie ( NYSE: ABBV) is set to report its first-quarter 2025 earnings on Friday, April 25, ahead of the market open. Wall ...

Google Photos is testing a new Ultra HDR tool that can dramatically improve the look of your pictures, regardless of how they were created. As revealed by Android Authority, this feature converts ...